Mayer Brown advised Mead Johnson Nutrition Company on its $1.5 billion public debt offering, consisting of $750 million of 3.0 percent senior notes due 2020 and $750 million of 4.125 percent senior notes due 2025. Mead Johnson, a global manufacturer of Enfamil infant formula and children’s nutrition products, used the proceeds to finance its stock repurchase program, including the repayment of a $1 billion short term loan facility. The facility had funded the acquisition of $1 billion of the company’s stock utilizing a forward purchase contract.

The Mayer Brown team included: Corporate & Securities partner David Schuette and associates Christine Shepard and Tyler Pate (all Chicago); Tax Transactions & Consulting partner Jim Barry (Chicago); and Banking & Finance partner Robert Baptista (Chicago) and counsel Pamela Sackmann (New York).